Literature DB >> 356761

Continuous and intermittent levamisole. A controlled trial.

J Scott, P A Dieppe, E C Huskisson.   

Abstract

A double-blind comparative trial showed that intermittent levamisole therapy (150 mg daily for 3 days of each week) was as effective as continuous therapy (150 mg daily) in rheumatoid arthritis and with slightly fewer side effects.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 356761      PMCID： PMC1000218          DOI： 10.1136/ard.37.3.259

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  5 in total

1.  Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors:  D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal:  Q J Med       Date:  1968-07

2.  Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.

Authors:  P L Boardman; F D Hart
Journal:  Br Med J       Date:  1967-11-04

3.  Immunotherapy with levamisole in rheumatic diseases.

Authors:  M Rosenthal; U Trabert; W Müller
Journal:  Scand J Rheumatol       Date:  1976       Impact factor: 3.641

4.  Letter: Levamisole in rheumatoid arthritis.

Authors:  E M Veys; H Mielants; A de Bussere; L Decrans; P Gabriel
Journal:  Lancet       Date:  1976-04-10       Impact factor: 79.321

5.  Immunostimulant therapy with levamisole for rheumatoid arthritis.

Authors:  E C Huskisson; J Scott; H W Balme; P A Dieppe; J Trapnell; D A Willoughby
Journal:  Lancet       Date:  1976-02-21       Impact factor: 79.321
  5 in total
  3 in total

1.  Levamisole monotherapy for oral lichen planus.

Authors:  Tai Hyok Won; Se Young Park; Bo Suk Kim; Phil Seung Seo; Seok Don Park
Journal:  Ann Dermatol       Date:  2009-08-31       Impact factor: 1.444

2.  Cellular phagocytic studies in rheumatoid arthritis patients treated with levamisole.

Authors:  K M Wynne; P A Dieppe; J Scott; E C Huskisson
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

3.  Rectal ulcer associated with levamisole.

Authors:  G V Bradby; M F Shadforth; A M Hoare
Journal:  Ann Rheum Dis       Date:  1979-08       Impact factor: 19.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.